These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 27105563)

  • 1. Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine.
    Beran J; Van Der Meeren O; Leyssen M; D'silva P
    Vaccine; 2016 May; 34(24):2686-91. PubMed ID: 27105563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
    Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
    Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to hepatitis B persists in adolescents 15-16 years of age vaccinated in infancy with three doses of hepatitis B vaccine.
    Van Der Meeren O; Behre U; Crasta P
    Vaccine; 2016 May; 34(24):2745-9. PubMed ID: 27095043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory].
    Chlibek R; Smetana J; Bostíková V; Splino M
    Epidemiol Mikrobiol Imunol; 2011 Sep; 60(3):99-108. PubMed ID: 22132651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody persistence and immune memory in adults, 15 years after a three-dose schedule of a combined hepatitis A and B vaccine.
    Van Damme P; Leroux-Roels G; Crasta P; Messier M; Jacquet JM; Van Herck K
    J Med Virol; 2012 Jan; 84(1):11-7. PubMed ID: 22052690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term immunogenicity and immune memory after two doses of the adult formulation of a combined hepatitis A and B vaccine in children 1 to 11 years of age.
    van Damme P; Kafeja F; Van Der Wielen M; Leyssen M; Jacquet JM
    Pediatr Infect Dis J; 2011 Aug; 30(8):703-5. PubMed ID: 21346683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
    Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
    Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years.
    Marshall H; Nolan T; Díez Domingo J; Rombo L; Sokal EM; Marès J; Casanovas JM; Kuriyakose S; Leyssen M; Jacquet JM
    Vaccine; 2010 Jun; 28(27):4411-5. PubMed ID: 20434544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents.
    Beran J; Kervyn D; Wertzova V; Hobzova L; Tichy P; Kuriyakose S; Leyssen M; Jacquet JM
    Vaccine; 2010 Aug; 28(37):5993-7. PubMed ID: 20637766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years.
    Chlibek R; von Sonnenburg F; Van Damme P; Smetana J; Tichy P; Gunapalaiah B; Leyssen M; Jacquet JM
    J Travel Med; 2011; 18(2):145-8. PubMed ID: 21366801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
    Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
    Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
    Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
    Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-dose combined vaccine against hepatitis A and hepatitis B in healthy children and adolescents compared to the corresponding monovalent vaccines.
    Ramonet M; da Silveira TR; Lisker-Melman M; Rüttimann R; Pernambuco E; Cervantes Y; Cañero-Velasco MC; Falleiros-Carvalho LE; Azevedo T; Targa-Ferreira C; Clemens SA
    Arch Med Res; 2002; 33(1):67-73. PubMed ID: 11825634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.
    Van Herck K; Jacquet JM; Van Damme P
    J Med Virol; 2011 Nov; 83(11):1885-91. PubMed ID: 21915861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine.
    Cardell K; Akerlind B; Sällberg M; Frydén A
    J Infect Dis; 2008 Aug; 198(3):299-304. PubMed ID: 18544037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
    Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune memory at 17-years of follow-up of a single dose of live attenuated hepatitis A vaccine.
    Chen Y; Zhou CL; Zhang XJ; Hao ZY; Zhang YH; Wang SM; Ma JC; Zhao G; Qiu C; Zhao YL; Wang B; Wang XY
    Vaccine; 2018 Jan; 36(1):114-121. PubMed ID: 29183734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
    Kurugöl Z; Mutlubaş F; Ozacar T
    Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.